Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases.

Sixteen patients presented with B cell leukaemia (white cell count 26-269 x 10(9)/l) which could not be classified as chronic lymphocytic (CLL), prolymphocytic leukaemia, or follicular lymphoma in leukaemic phase. Eleven patients (10 men, one woman) corresponded histologically to intermediate (INT) or mantle zone lymphoma, and five, with less well defined features, were designated small lymphocytic lymphoma with cleaved cells. The blood films showed a pleomorphic picture with lymphoid cells of predominantly medium size with nuclear irregularities and clefts. The membrane phenotype of the circulating cells showed strong immunoglobulin staining and reactivity with CD5 and FMC7 in all cases tested; CD10 was positive in six out of nine cases. The membrane phenotype of two of the five cases of small lymphocytic lymphoma was close to those of B-CLL and three resembled INT lymphoma. Bone marrow trephine biopsy specimens showed a diffuse pattern of infiltration in INT lymphoma. The median survival of these patients was less than two years, suggesting that a leukaemic presentation is associated with poor prognosis. By combining data from histology, membrane markers, and peripheral blood morphology, the leukaemic phase of typical INT lymphoma can be defined in most cases.

[1]  H. Yamabe [Histopathology of malignant lymphomas]. , 1990, Rinsho byori. The Japanese journal of clinical pathology.

[2]  J. Melo,et al.  Morphology and immunology of circulating cells in leukaemic phase of follicular lymphoma. , 1988, Journal of clinical pathology.

[3]  E. Jaffe,et al.  Lymphocytic lymphoma of intermediate differentiation--mantle zone lymphoma: a distinct subtype of B-cell lymphoma. , 1987, Human pathology.

[4]  J. Melo,et al.  Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal. , 1987, Blood cells.

[5]  D. Weisenburger,et al.  Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings. , 1987, Blood.

[6]  J. Melo,et al.  The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia , 1986, British journal of haematology.

[7]  N. Harris,et al.  Mantle-zone lymphoma: A pattern produced by lymphomas of more than one cell type , 1985, The American journal of surgical pathology.

[8]  N. Harris,et al.  Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities. , 1984, The American journal of pathology.

[9]  V. Tertov,et al.  Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells. , 1984, The American journal of pathology.

[10]  L. Neckers,et al.  Low-grade lymphomas. Expression of developmentally regulated B-cell antigens. , 1984, The American journal of pathology.

[11]  T. Lister,et al.  Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. , 1983, The American journal of pathology.

[12]  D. Weisenburger,et al.  Mantle‐zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma , 1982, Cancer.

[13]  D. Catovsky,et al.  Prolymphocytic Leukaemia , 1974, British journal of haematology.

[14]  B. Nathwani,et al.  Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases , 1981, Cancer.

[15]  Prof. Dr. med. Karl Lennert,et al.  Malignant Lymphomas Other than Hodgkin’s Disease , 1978, Handbuch der Speziellen Pathologischen Anatomie und Histologie.

[16]  E. Jaffe,et al.  Functional markers: a new perspective on malignant lymphomas. , 1977, Cancer treatment reports.